Skip to content

Clinical trials

Myeloproliferative Disorders trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Belgium Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20052
20091
20101
20111
20121
20132
20144
20151
20161
20171
20194
20203
20217
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated10
Active, not recruiting6
Recruiting6
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation8
European Organisation for Research and Treatment of Cancer - EORTC4
Novartis Pharmaceuticals4
Celgene3
Ariad Pharmaceuticals2
CTI BioPharma2
University of Liege2
AbbVie1
Cogent Biosciences, Inc.1
Constellation Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders34
Primary Myelofibrosis20
Polycythemia Vera11
Thrombocythemia, Essential11
Hematologic Diseases10
Myelodysplastic Syndromes10
Bone Marrow Diseases8
Leukemia, Myeloid, Acute8
Leukemia7
Leukemia, Myelomonocytic, Chronic7

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.